Enterprise-Wide License

Showing 253–264 of 286 results

  • Improving Patient Recruitment in Biosimilar Trials

    $3,260.00$6,520.00
  • Primer: Biosimilars in the US Oncology Market

    $880.00$1,760.00
  • CRO Quality Benchmarking – Phase I Service Providers (4th Edition)

    $4,900.00$9,800.00
  • Chronic Obstructive Pulmonary Disease (COPD): Market, Treatment, and Development Overview

    $4,900.00$9,800.00
  • MSL and Sales Strategies for the US Oncology Market

    $4,900.00$9,800.00
  • Optimizing Investigator Recruitment in Clinical Trials

    $2,460.00$4,920.00
  • Optimizing Patient Recruitment in Clinical Trials

    $2,460.00$4,920.00
  • CRO Quality Benchmarking – Phase II/III Service Providers (4th edition)

    $6,800.00$13,600.00
  • Optimizing Feasibility in Clinical Trials

    $2,460.00$4,920.00
  • US Payers: Comparative Effectiveness Research (CER) and Formulary Decision-making

    $4,900.00$9,800.00
  • Electronic Detailing vs. In-person Detailing (US)

    $4,900.00$9,800.00
  • Primer: A View of Biosimilars from the Pharmacy

    $475.00$700.00